These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7116345)

  • 1. Behavioral alterations and the therapy of parkinsonism.
    Klawans HL
    Clin Neuropharmacol; 1982; 5 Suppl 1():S29-37. PubMed ID: 7116345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of organic bipolar mood disorders in Parkinson's disease.
    Kim E; Zwil AS; McAllister TW; Glosser DS; Stern M; Hurtig H
    J Neuropsychiatry Clin Neurosci; 1994; 6(2):181-4. PubMed ID: 8044042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine in Parkinsonism.
    Pearce I; Pearce JM
    Br Med J; 1978 May; 1(6124):1402-4. PubMed ID: 348261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease.
    Rosenthal SH; Fenton ML; Harnett DS
    Gen Hosp Psychiatry; 1992 Jul; 14(4):285-6. PubMed ID: 1505751
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychological changes in Parkinson disease].
    Danielczyk W
    Wien Med Wochenschr; 1986 Aug; 136(15-16):396-9. PubMed ID: 3788191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease: drug-induced psychiatric states.
    Factor SA; Molho ES; Podskalny GD; Brown D
    Adv Neurol; 1995; 65():115-38. PubMed ID: 7872135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levodopa dependency in Parkinson's disease: case report and review].
    Müller U; Reuter M; Hermann W; Gertz HJ
    Nervenarzt; 2002 Sep; 73(9):887-91. PubMed ID: 12215883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
    Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A
    Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clozapine, a valuable contribution for the treatment of psychoses in Parkinson disease].
    Andersson U; Freccero-Rosman K; Aquilonius SM; Nylander B; Lindvall O; Odin P
    Lakartidningen; 1992 Dec; 89(49):4244-6. PubMed ID: 1461047
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinson's disease, depression, and the on-off phenomenon.
    Friedenberg DL; Cummings JL
    Psychosomatics; 1989; 30(1):94-9. PubMed ID: 2913602
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of Parkinson's disease.
    Morris JG
    Med J Aust; 1985 Oct; 143(8):347-50. PubMed ID: 4046949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa addiction in idiopathic Parkinson disease.
    Borek LL; Friedman JH
    Neurology; 2005 Nov; 65(9):1508. PubMed ID: 16275855
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.
    Nausieda PA; Weiner WJ; Kaplan LR; Weber S; Klawans HL
    Clin Neuropharmacol; 1982; 5(2):183-94. PubMed ID: 7139632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
    Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Fischer PA; Przuntek H; Majer M; Welzel D
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease.
    Vogel HP; Schiffter R
    Pharmacopsychiatria; 1983 Jul; 16(4):107-10. PubMed ID: 6685318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
    Godwin-Austen RB; Smith NJ
    J Neurol Neurosurg Psychiatry; 1977 May; 40(5):479-82. PubMed ID: 330825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depressive pseudodementia in early Parkinson's disease: lessons from a case with long-term follow-up].
    Giménez-Roldán S; Mateo D; Dobato JL
    Neurologia; 1997 Mar; 12(3):130-5. PubMed ID: 9198454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.